Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation

US6214992A · kind A · utility

Assignee

• Hoechst GmbH · DE

Inventors

• Ulrich Gebert · Königstein, DE
• Erhard Wolf · Hofheim, DE
• Elisabeth Defossa · Idstein, DE
• Uwe Heinelt · Wiesbaden, DE
• Hiristo Anagnostopulos · Wiesbaden, DE
• Karl Rudolphi · Mainz, DE
• John J. Grome · Wiesbaden, DE

Key dates

• Filing date: Jun 4, 1997
• Grant date: Apr 10, 2001
• Expiry date: Jun 4, 2017

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Theophylline derivatives having at least one ether function in the structurally modified methyl radical in the 1-position that are useful in the treatment and prophylaxis of states of shock, new xanthine compounds having this substitution pattern, and processes for their preparation.